John Libbey Eurotext

Antimyoclonic effect of levetiracetam Volume 2, numéro 4, Décembre 2000


  • Antimyoclonic effect of levetiracetam
Centre Saint-Paul, 300, boulevard Saint-Marguerite, 13009 Marseille, France.
  • Page(s) : 209-12
  • Année de parution : 2001

Patients and methods Three patients with debilitating myoclonus volunteered and gave their informed consent for a short-term, open trial with LEV which was available in limited amounts at the time of this study. Patient 1 had recently been referred for the treatment of post-anoxic myoclonus (PAM), patients 2 and 3 had been followed for many years and diagnosed with Unverricht-Lundborg disease (ULD) [11], a progressive myoclonus epilepsy [...]